Pentraxin 3 is an inflammation-related biomarker that distinguishes early-stage from mid-advanced cardiovascular-kidney-metabolic syndrome. [PDF]
Xu Z +9 more
europepmc +1 more source
Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study. [PDF]
Masuda T +23 more
europepmc +1 more source
Galectin-9, FABP4 and pentraxin-3 are associated with myocardial dysfunction and discriminate chemotherapy-related cardiac dysfunction in anthracycline-treated breast cancer: a single-centre retrospective study. [PDF]
Ma J +5 more
europepmc +1 more source
High Local and Systemic Expression of Pentraxin-3 in Anaplastic Thyroid Cancer. [PDF]
Bojoga A +9 more
europepmc +1 more source
Pentraxin-3 and Lipocalin-2 are decreased in patients with uveal effusion syndrome. [PDF]
Havertz C +6 more
europepmc +1 more source
The long pentraxin 3: the invisible loom weaving the warp and weft of tumor destiny. [PDF]
Liu T +11 more
europepmc +1 more source
Pentraxin 3 Levels Reflect Inflammatory and Parasitic Activity in Human Visceral Leishmaniasis. [PDF]
Diniz LFB +5 more
europepmc +1 more source
Exploring the pentraxin-3 as a prognostic biomarker in paraquat poisoning: a systematic-narrative hybrid review. [PDF]
Mathew D, Patra AP.
europepmc +1 more source
Impact of Exercise Modalities on Pentraxin-3 (PTX3) Levels: A Systematic Review and Meta-Analysis. [PDF]
Rahimi MR +5 more
europepmc +1 more source
Pentraxin 3 deficiency exacerbates neutrophilic inflammation and airway hyperresponsiveness in type 2-low asthma. [PDF]
Taefehshokr S +5 more
europepmc +1 more source

